Werth, B. J., Ashford, N. K., Penewit, K., Waalkes, A., Holmes, E. A., Ross, D. H., . . . Xu, L. (2021). Dalbavancin exposure in vitro selects for dalbavancin-non-susceptible and vancomycin-intermediate strains of methicillin-resistant Staphylococcus aureus. Clinical Microbiology & Infection, 27(6), 910.e1. https://doi.org/10.1016/j.cmi.2020.08.025
Chicago Style (17th ed.) CitationWerth, Brian J., et al. "Dalbavancin Exposure In vitro Selects for Dalbavancin-non-susceptible and Vancomycin-intermediate Strains of Methicillin-resistant Staphylococcus Aureus." Clinical Microbiology & Infection 27, no. 6 (2021): 910.e1. https://doi.org/10.1016/j.cmi.2020.08.025.
MLA (9th ed.) CitationWerth, Brian J., et al. "Dalbavancin Exposure In vitro Selects for Dalbavancin-non-susceptible and Vancomycin-intermediate Strains of Methicillin-resistant Staphylococcus Aureus." Clinical Microbiology & Infection, vol. 27, no. 6, 2021, p. 910.e1, https://doi.org/10.1016/j.cmi.2020.08.025.